摘要 |
The use of a compound of formula (I) in the manufacture of a medicament for the treatment, in a warm-blooded animal, of disorders mediated by the neuropeptide Y5 receptor: wherein: R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3 </SUB>and X<SUP>1</SUP>-X<SUP>6 </SUP>are as defined within or a pharmaceutically acceptable salt, prodrug or solvate thereof, is described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are also described. |